A technique of TA-assisted ILM peeling for myopic foveoschisis

Liyan Ye1,2, Luyun Liang1,2, Xiaolan Liu1,2

  • 1JiNan University, No. 601, West Huangpu Avenue, Tianhe District, Guangzhou City, Guangdong Province, 510632, China.

BMC Surgery
|December 11, 2025
PubMed
Abstract

Insights

Triamcinolone Acetonide (TA) is a viable option for internal limiting membrane peeling in myopic foveoschisis (MF) surgery. This technique showed comparable outcomes to indocyanine green (ICG) in improving visual acuity and reducing retinal thickness.

Area of Science:

  • Ophthalmology
  • Retinal Surgery

Background:

  • Myopic foveoschisis (MF) is a condition affecting the macula in highly myopic eyes.
  • Internal limiting membrane (ILM) peeling is a key surgical step in treating MF.
  • Traditional ILM staining agents like indocyanine green (ICG) can be challenging due to posterior vitreous adhesion.

Purpose of the Study:

  • To evaluate the clinical efficacy of Triamcinolone Acetonide (TA) versus ICG in fovea-sparing internal limiting membrane peeling (FILMP) for MF.
  • To compare postoperative outcomes, including visual acuity, retinal thickness, and complications, between TA-assisted and ICG-assisted FILMP.

Main Methods:

  • A prospective study involving 66 patients (72 eyes) with MF undergoing 25-gauge pars plana vitrectomy (PPV) with FILMP.
  • Patients were divided into two groups based on the ILM staining agent: TA group and ICG group.
  • Preoperative and postoperative assessments included visual acuity, optical coherence tomography (OCT), and fundus photography.

Main Results:

  • Both TA-assisted and ICG-assisted FILMP significantly improved visual acuity and reduced central retinal thickness (CRT) postoperatively.
  • The incidence of postoperative full-thickness macular hole (MH) was low (4.9%) and similar between groups.
  • No significant differences were observed between the TA and ICG groups regarding MH incidence, visual acuity, CRT, or MF recovery.

Conclusions:

  • Triamcinolone Acetonide (TA) is a feasible and effective agent for ILM peeling in MF surgery, adhering well to the vitreous cortex.
  • TA-assisted FILMP offers comparable clinical outcomes to ICG-assisted FILMP in treating myopic foveoschisis.
  • Further large-scale, randomized controlled trials are recommended to validate these findings.

Related Concept Videos